Serina Therapeutics (SER) Debt Ratio (2017 - 2025)

Serina Therapeutics has disclosed Debt Ratio across 9 years of filings, most recently posting 0.23 for Q3 2025.

• In Q3 2025, Debt Ratio fell 84.49% year-over-year to 0.23; the TTM figure through Sep 2025 stood at 0.23 (down 84.49% YoY), while the FY2022 annual figure was 5.64, up 33.93% from the prior year.
• Debt Ratio came in at 0.23 for Q3 2025 at Serina Therapeutics, down from 1.5 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 66.42 in Q2 2023 to a low of 0.18 in Q3 2023.
• Average Debt Ratio over 5 years is 11.23, with a median of 4.0 recorded in 2022.
• Year-over-year, Debt Ratio soared 1411.58% in 2023 and slumped 98.43% in 2024.
• Over 5 years, Debt Ratio stood at 4.21 in 2021, then soared by 33.93% to 5.64 in 2022, then sank by 96.78% to 0.18 in 2023, then soared by 725.56% to 1.5 in 2024, then slumped by 84.49% to 0.23 in 2025.
• Per Business Quant data, the three most recent Debt Ratio figures were 0.23 in Q3 2025, 1.5 in Q3 2024, and 1.04 in Q2 2024.